mentions p
You are not allowed to view links.
Register or Login
With your permission I would like to highlight the last part of the article, saying:
"What does this mean to people with autoimmune disease?
The results of this experiment open the door to investigate imatinib mesylate as a potential treatment for RA. Furthermore, identifying the chemical pathways affected by this drug lead researchers to believe that imatinib may be of benefit in other autoimmune diseases, such as Crohn's disease, psoriasis and multiple sclerosis. In particular, one mechanism of action disrupts a pathway that results in fibrosis, leading researchers to believe that imatinib may be of benefit in scleroderma and idiopathic pulmonary fibrosis."
That does sound good.
